XLV241220P85000
- 0.00
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
After more than two years, Eli Lilly and Co's weight loss drug Zepbound is finally no longer in short supply.
① The FDA announced that Eli Lilly and Co's weight loss drug Zepbound shortage issue has been resolved, impacting the multi-billion dollar compounded drug market, causing Hims & Hers Health's stock price to drop by over 10%; ② The FDA requires compound pharmacies to stop producing compounded versions of tirzepatide within 60 to 90 days, to allow patients to transition to FDA-approved brand medications.
Stock Of The Day: Where Does The Merck Downtrend End?
Behind the Scenes of Intuitive Surgical's Latest Options Trends
Hims & Hers Health Falls as FDA Issues Unfavorable Compounded GLP-1 Decision
Sector Update: Health Care Stocks Mixed Premarket Thursday
AbbVie's Atogepant And OnabotulinumtoxinA Receive Strong Recommendations In The Newly Updated Canadian Headache Society Migraine Prevention Guideline; A Strong Recommendation Was Issued When An Intervention Was Deemed Suitable For The Majority Of...
SA Sentiment Showed Two Rate Cuts for 2025 Before Fed's Latest 'Dot Plot'
Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.
①The plan of the USA's incoming president Trump to impose tariffs does not seem to be popular among the public. According to a poll, 51% of USA voters oppose imposing tariffs on commodities from Mexico, Canada, and China; ②Standard & Poor's states that USA tariffs will increase inflation rates and reduce economic output, while some citizens and businesses are stockpiling goods due to tariff concerns, leading to a significant increase in throughput at the ports of Los Angeles and Long Beach in November.
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
This Is Why You Should Turn Defensive, Underweight Cyclicals – UBS
Who's Next To Join Tesla, Broadcom In $1 Trillion Club? Over 50% Say The World's Biggest Retailer
10 Health Care Stocks With Whale Alerts In Today's Session
Dow's Drop: How Blue-chips Have Fared During Index's Peak Turned Worst-run in Decades
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Merck-Hansoh Deal for Oral GLP-1 Hurts Obesity Drug Developers
Least Shorted S&P 500 Stocks in November
Lilly Rival Gets FDA Okay for Phase 2 Study of Obesity Drug
Intuitive Surgical Analyst Ratings
Decoding UnitedHealth Group's Options Activity: What's the Big Picture?